The study of the isotopic fractionation of endogen elements and toxic heavy metals in living organisms for biomedical applications, and for metabolic and toxicological studies, is a cutting-edge research topic. This paper shows that human neuroblastoma cells incorporated small amounts of uranium (U) after exposure to 10 μM natural U, with preferential uptake of the 235 U isotope with regard to 238 U. Efforts were made to develop and then validate a procedure for highly accurate n( 238 U)/n( 235 U) determinations in microsamples of cells. We found that intracellular U is enriched in 235 U by 0.38 ± 0.13‰ (2σ, n = 7) relative to the exposure solutions. These in vitro experiments provide clues for the identification of biological processes responsible for uranium isotopic fractionation and link them to potential U incorporation pathways into neuronal cells. Suggested incorporation processes are a kinetically controlled process, such as facilitated transmembrane diffusion, and the uptake through a highaffinity uranium transport protein involving the modification of the uranyl (UO 2 2+ ) coordination sphere. These findings open perspectives on the use of isotopic fractionation of metals in cellular models, offering a probe to track uptake/transport pathways and to help decipher associated cellular metabolic processes.
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isotopic fractionation | uranium | neuronal cells | analytical procedure development | microsamples I sotopic variations of an element in nature can be the result of isotopic differences in sources, radioactive decay of unstable isotopes, cosmogenic processes, or isotopic fractionation during chemical, physical, or biological processes. The isotopic fractionation of medium-mass endogen elements (i.e., Ca, Fe, Cu, and Zn) has recently been shown to have an outstanding potential for biomedical applications (1) . Isotopic fractionation measurements have been identified as new biomarkers for the investigation of metabolic processes (2-6) and as powerful tools for the early detection of diseases (7) (8) (9) (10) (11) (12) . Studies of Cu and Zn isotopic fractionation are very promising for the early diagnosis of different types of cancer (9, 12) and neurodegenerative diseases (8, 13) , whereas Fe and Ca isotopic fractionation measurements have shown their ability to monitor Fe absorption efficiency (3) and bone mineral balance (7), respectively. Concerning high-mass elements, only a few in vivo studies have been reported, within the framework of toxicity investigations and identification of contamination sources, that seem to suggest that isotopic fractionation occurs during metabolic processes for elements such as Pb and Hg (14) (15) (16) . However, very little knowledge is available on the processes occurring at the molecular or cellular level that lead to the isotopic fractionation observed during metal transport in living organisms. Furthermore, the lack of investigation regarding isotopic fractionation in cellular models has recently been stressed (17) . Such in vitro studies would be invaluable in understanding the processes at the origin of isotopic fractionation and to link these processes to cellular pathways of metals. This information would be of prime importance in toxicological studies and would help in the interpretation of clinical results. The additional advantages of in vitro cell cultures are that they prevent isotopic variations associated with external sources, and make it possible to carry out numerous studies without human samples collection. To our knowledge, only three studies have shown in vitro isotopic fractionation in prokaryotic models during adsorption and incorporation of Cu, Zn, and Fe into bacteria (18) (19) (20) . A recent publication deals with Cu isotopic fractionation in human cell line HepG2 (21) . It has been demonstrated that, under hypoxic conditions, intracellular Cu was isotopically heavier than under normoxic conditions. This result is in agreement with the enrichment in 65 Cu in the tumor tissue of hepatocellular carcinoma with regard to the healthy surrounding tissue (9) , thus suggesting that the tumor hypoxia was at the origin of the difference in Cu isotopic signature.
Unlike processes at molecular and cellular levels, there is far more knowledge on the mechanisms leading to isotopic fractionation. The element nature and masses of associated isotopes, as well as the type of process/reaction involved, determine the operating mechanisms along with the magnitude and direction of fractionation. Isotopic fractionation observed for endogen elements in biological samples has been generally considered to arise from differences in "zero-point energies" (ZPE) for different isotopes (22, 23) , linked to differences in bond strength. This mechanism takes place for both kinetic and equilibrium processes; it leads to mass-dependent isotopic fractionation, resulting in the preferential concentration of light isotopes in the products of kinetically controlled processes, whereas heavy isotopes are accumulated in the
Significance
In vivo isotopic fractionation studies of metals in living organisms have recently revealed an outstanding potential for biomedical and toxicological studies. In vitro studies in cellular models are underexploited, although they have the potential to provide invaluable information to understand the processes at the origin of such isotopic fractionations. This work demonstrates the isotopic fractionation of natural uranium during its uptake by neuron-like human cells. The direction of isotopic fractionation provided clues for the identification of potential U incorporation pathways into cells, unknown until now. These findings open new perspectives on the use of isotopic fractionation of metals in cellular models for the investigation of metabolic processes, the identification of new biomarkers, and the interpretation of clinical results.
strongest bonds in the case of equilibrium reactions. However, it must be pointed out that the mass-independent isotopic fractionation of Fe in magnetotactic bacteria has recently been demonstrated (20) . Mass-independent fractionation mechanisms are typically found for high-mass elements. Two mass-independent fractionation mechanisms have been described: the nuclear field shift (NFS) effect (24, 25) and the nuclear spin or magnetic isotope effect (MIE) (15) . NFS is related to the different shape and volume of the atomic nucleus for different isotopes, and the nonnegligible interaction between electrons and the nucleus. MIE is caused by electron interaction with the nuclear magnetic moment associated with the nonzero spin of odd isotopes. These mass-independent fractionation mechanisms result in light isotope enrichment in species with the highest electronic density near the atomic nucleus.
Uranium is the heaviest element naturally present in the Earth's crust at significant amounts. U is ubiquitous, involving potential human exposure to small U amounts; the question of U fate and isotopic fractionation in samples of human origin can therefore be raised. The brain is a potential target of U (26) , and neurotoxic effects induced by depleted U in war conflict veterans have been suspected (27) . Historically, n( 238 U)/n( 235 U) fractionation has been considered to be very small or negligible because of the high atomic mass of U. However, the advent of multicollector inductively coupled plasma mass spectrometry (MC-ICPMS) has made it possible to measure low isotope ratio variations at around 0.1‰ uncertainty for U in complex samples. Uranium isotopic fractionation up to 5‰ has been observed in geological samples (28, 29) . For these samples, the predominant fractionation mechanism has been generally assumed to be the NFS effect in the case of U(VI)/ U(IV) redox reactions. NFS effect leads to the enrichment of the heavy 238 U isotope into the U(IV) species (30) (31) (32) . Some studies reported that these redox reactions can be mediated by sulfatereducing bacteria (33) (34) (35) , but, in these cases, only extracellular uranium was analyzed, and the potential processes occurring inside the bacteria were not investigated. The reductases involved in these reactions are thought to be electron-carrier proteins or enzymes, such as different c-type cytochromes, in the outer membrane, within the periplasm, and/or in the external part of the cytoplasmic membrane (36) . Stylo et al. (35) recently demonstrated that the uranium isotopic fractionation found during the biologically mediated U(VI) reduction by Shewanella oneidensis was not significantly different from that obtained when the redox reaction was performed in the presence of cell-free extracts of the same bacteria, thus confirming that the redox reaction is responsible for the isotopic fractionation observed. Smaller isotopic fractionation of around 0.2‰ was found during U adsorption to mineral phases, which was attributed to a ZPE mechanism (37) . In another framework, U(VI) complexation experiments gave rise to an enrichment of the light 235 U isotope in complexed U(VI) species (38) . Some of the physicochemical processes mentioned above may take place during the in vitro interaction between U and cells, which led us to hypothesize U's intracellular fractionation. To study the effects of small amounts of natural U on the neurological system, we investigated uranium isotopic fractionation during its uptake by SH-SY5Y human neuroblastoma cells. The direction of isotopic fractionation can provide valuable information for the identification of U incorporation pathways, unknown until now. SH-SY5Y cells differentiated into neuron-like cells (39) were exposed to a nontoxic uranium concentration (10 μM) for 7 d. As small amounts of U were expected in exposed cells, a fit-for-purpose analytical procedure aimed at controlling any type of analytical biases was developed to resolve U isotopic fractionation in these microsamples.
Results
Uranium Speciation in the Exposure Solutions. The composition of the exposure solution influences uranium speciation and therefore its bioavailability. In simulated biological fluids and culture media at physiological pH conditions (around 7.5), uranium is typically found under different complexes of hexavalent uranyl ion (UO 2 2+ ) and CO 3 2-ions (40) (41) (42) , which are the most common species found in human biological fluids. We developed a two-step protocol for the preparation of the exposure solution, consisting in the dilution of a natural uranium stock solution in a buffer, and the further dilution of this intermediate solution in the culture medium (SI Materials and Methods). This protocol was developed with a triple objective. First, we need to avoid uranyl precipitation when preparing the exposure solutions from the culture medium, containing high phosphate concentrations. Precipitation could lead not only to a significant reduction in the soluble uranium concentration in the exposure solutions but also to U isotopic fractionation during the transition into a solid phase. For this reason, uranium was first stabilized under Triscarbonate uranyl (VI) complexes [UO 2 (CO 3 ) 3 ] 4− in the intermediate solution. Second, the high uranium concentration in the stock solution made it possible to prepare the 10 μM U exposure solutions without significantly modifying the culture medium composition and consequently the uranium speciation. Finally, our protocol made it possible to have Tris-carbonate uranyl complexes in the exposure solutions. Based on the thermodynamic constants available in the literature (43) (44) (45) (46) , and from the different literature surveys on biological ligands of U(VI) (47-55), we obtained the theoretical speciation diagram of U in the exposure solution shown in Fig. 1 . During cell culture experiments, the pH value of the exposure solution did change from ∼8 to ∼7. Below pH 7.3, a precipitation of KUO 2 PO 4 :3H 2 O could occur (Fig. 1 ). Using ICPMS, we checked that U concentration in the exposure solutions remained constant throughout the experiments, demonstrating that U did not precipitate. Therefore, it can be assumed that the U speciation in the exposure solution was that corresponding to the plateau of Fig. 1 at a Isotopic Analysis of Uranium in Neuronal Cell Samples. Human neuronal cell samples were exposed to 10 μM U solutions. Seven independent exposure experiments were performed, and cells incorporated from 200 ng to 1,300 ng of U (Table 1) , corresponding to less than 1% of the uranium amount in the exposure solutions. A careful purification protocol of digested samples using a uraniumspecific purification resin was required for high-precision MC-ICPMS isotope ratio measurements. Element purification can lead to isotopic fractionation whenever recoveries are not complete (56) , although this is not expected for uranium purification using the resins used in this work (32) . Matrices of cell samples and exposure solutions are complex, even after acid digestion, and may complicate the purification step. Furthermore, given the small uranium amounts in cell samples, high dilution factors cannot be applied to purified samples before analysis. Therefore, significant matrix effects during MC-ICPMS measurements can occur due to the presence of leftover reagents used for the purification or material leached from the resin bed. To test these potential effects, the δ 238 (Eq. S12) was determined for several replicates of a procedure control solution (for definition, see SI Materials and Methods), and for two uranium-free culture medium solutions and two uranium-free cell samples, both spiked with Institute for Reference Materials and Measurements (IRMM)-184 material. The average δ 238 value found for the procedure control solution was −0.27 ± 0.09‰ (2σ, n = 9) relative to the IRMM-184 n ( 238 U)/n( 235 U) certified value (Fig. 2) , which is well within the expanded uncertainty of the n( 235 U)/n( 238 U) certified value (±0.3‰, k = 2). This value was not significantly different from the mean of the δ 238 values determined for replicate measurements of the mass bias control solution (−0.29 ± 0.10‰, 2σ, n = 21) performed during these measurement sessions (Fig. 2) . The δ 238 values found for the spiked samples (empty triangles and squares, Fig. 2) were not significantly different from these values either. These results demonstrate that there is no significant bias induced either by the analytical procedure or by the sample matrices.
The natural uranium stock solution was isotopically characterized, and the δ 238 relative to the certified n( 238 U)/n( 235 U) of IRMM-184 material was found to be +0.66 ± 0.12‰ (2σ, n = 7). The δ 238 values relative to the stock solution were then determined for both extracellular U in exposure solutions and intracellular U (Fig. 3) . The δ 238 values for extracellular U before exposure experiments were +0.04 ± 0.12‰ (2σ, n = 7), thus excluding any U isotopic fractionation during the preparation of exposure solutions, whereas, for intracellular uranium, the δ 238 was −0.34 ± 0.13‰ (2σ, n = 7).
Discussion
Whatever the route of entry into the body, U(VI) reaches the blood and, from there, its target organs within few hours (57) . Although the mechanisms leading to uranium accumulation in the different target organs are not described, uranium is incorporated by their cells. Our results demonstrate that human neuron-like cells incorporate, preferentially, the light 235 U isotope. The similar intracellular U isotopic composition found for the seven independent experiments, irrespective of the U amount incorporated by cells, raises the question of a preferential uranium incorporation pathway. The interpretation of fractionation origins during the cellular incorporation of an element is, nevertheless, extremely complex because many processes can take place simultaneously (19) : adsorption, diffusion, ligand exchange reactions, redox reactions, etc. Furthermore, element speciation in the culture medium may have a significant impact on the magnitude of isotopic fractionation (19) . In our exposure solutions, the predominant species were soluble U(VI) carbonate complexes and corresponding alkaline earth ion pairs (Fig. 1) . Our methodology was designed to study U isotopic fractionation in vitro under normoxic conditions, for which the speciation of U is close to that expected in the circulating blood. However, it cannot be excluded that, in the body, U speciation and isotopic fractionation could be more complex because of heterogeneous oxygen environments, such as hypoxia, as recently observed by Bondanese et al. (21) for Cu isotopic fractionation in cancerous cells. Biotic reduction studies have demonstrated the uranium isotopic fractionation during the reduction of U(VI) to U(IV) mediated by bacteria (33) (34) (35) . However, in agreement with results reported for other mammalian cells (58-61), we can exclude U(VI) reduction in the case of the SH-SY5Y cells used in this study. Results obtained for bacteria show that the reduction reaction gives rise to the enrichment of the heavy isotope 238 U in the U(IV) species in agreement with an NFS effect, which is not compatible with the enrichment in the light isotope 235 U for intracellular uranium found in our study.
Based on our results, two potential processes of isotopic fractionation can be suggested (Fig. 4) . First, a kinetic process, such as facilitated diffusion through a protein channel, can be responsible for the isotopic fractionation observed. In this case, a mass-dependent ZPE fractionation mechanism would operate and species containing the light 235 U isotope would diffuse faster, thus resulting in lower δ 238 values for intracellular than for extracellular uranium. Second, a mass-independent NFS mechanism associated with the modification of the U(VI) coordination sphere during its uptake is also compatible with our results. In the case of the NFS mechanism, generally dominating uranium isotopic fractionation in equilibrium reactions, 235 U isotopes are expected to preferentially accumulate in the species exhibiting the highest electronic densities near the uranium nucleus. Therefore, we can hypothesize the transport of U(VI)-carbonate complexes into cells through the formation of a complex with a transport protein, involving the exchange of carbonate(s) for stronger ligand(s). Indeed, the high affinity of U(VI) for certain proteins has been recently demonstrated (62) (63) (64) . Using the total energies of U(VI) compounds reported in literature for theoretical calculations of fractionation factors associated with an NFS effect for the reduction of [UO 2 ). The resulting data made it possible to confirm that 235 U isotopes would preferentially concentrate in the species containing the strongest ligands (Table S1) in the case of an NFS mechanism. At this stage of the study, determining the respective contributions of mass-dependent ZPE and mass-independent NFS fractionation mechanisms is complex, as there are only two uranium isotopes found in sufficient abundances for high-precision isotope ratio measurements in natural uranium. The isotopic fractionation observed in this work might raise the question of the magnitude of radiation effects on target organs, resulting from the potential enrichment of the most radioactive isotopes of radionuclides through successive biological processes following exposure/contamination. Therefore, we calculated the variation in the effective dose after natural uranium fractionation during its incorporation into cells. A negligible increase of 0.01% was found.
In summary, a resolvable isotopic fractionation of natural uranium was demonstrated in human cells differentiated into neuronlike cells, despite the very small U amounts incorporated. Our fractionation results have thus made it possible to identify potential incorporation pathways for U(VI) species, unknown until now. Work is currently in progress to identify specific intracellular proteins able to bind uranium, as well as determining the quantitative subcellular distribution of uranium within the cells. Isotopic fractionation is also likely to occur for lighter elements in other in vitro cell models, and such studies have the potential to provide clues to deciphering the processes governing metal uptake, assimilation, storage, distribution, and efflux at the cellular level. More broadly, this work paves the way for using isotopic fractionation in in vitro cellular models as a probe to explore toxicity mechanisms induced by heavy metals and radionuclides or to study any other type of stress, such as certain diseases, as recently demonstrated (21) . Such an approach could play a fundamental role in identifying sources of metal contamination or in improving preventive and diagnostic strategies, as well as in developing specific curative treatments. Pathway B corresponds to a three-step incorporation process consisting of (step 1) the formation of a complex with a high-affinity uranium transport protein through the exchange of one or more carbonates; (step 2) the transport of uranyl through the transport protein; and (step 3) the binding of uranyl to intracellular metabolites/proteins. . Values for extracellular and intracellular uranium were statistically different according to a t test (***P < 0.001).
Materials and Methods
from 84 to 91%, with an SD of 3%. The number of cells per replicate was around 40 × 10 6 cells (Table 1) in the 175-cm 2 flasks. These conditions offered the best compromise between requirements for the differentiation/exposure experiments and for high-precision isotope ratio determinations. Cells pellets were stored at −80°C until use.
Sample Preparation for Isotopic Measurements. Sample preparation and analysis were performed at the Laboratoire de développement Analytique, Nucléaire, Isotopique et Elémentaire. The labware used for sample preparation previous to isotopic measurements was systematically prewashed with acid solutions in accordance with clean laboratory practices. Fig. S1 shows a schematic diagram of the sample preparation steps applied before isotopic measurements. Cell pellets and exposure solutions (2 mL) were digested in 15-mL polypropylene tubes at room temperature for at least 48 h by adding 2 mL of 34 to 37% (wt/vol) HCl and 2 mL of 67 to 70% (wt/vol) HNO 3 . Digested samples were then transferred to Savillex vessels with the aid of 1.5 mL of ultrapure water (five washes of 0.3 mL), and the solution was evaporated to dryness at 85°C using a heating block. A second digestion step was carried out with 1 mL of 67 to 70% (wt/vol) HNO 3 in closed Savillex at 85°C for 2 h. The acid was then evaporated at 85°C until dry, and the residue was redissolved in 1.1 mL of 3 M HNO 3 . An aliquot of 0.1 mL of this solution was used to determine the mass of uranium incorporated by cells by quadrupole ICPMS ( Table 1 ). The remaining 1 mL was used for isotope ratio measurements. All samples/solutions subjected to the analytical procedure were spiked with IRMM-3636 before uranium purification to correct for any potential isotopic fractionation during the purification step. The amount of this material was adapted to obtain a signal of around 2 V on 233 U + and 236 U + isotopes during subsequent MC-ICPMS measurements.
A uranium purification protocol by gravitational chromatography was set up using UTEVA resins (100 μm to 150 μm; Eichrom) prepacked in 2-mL cartridges.
For the first step, the resin was cleaned with 5 mL of 0.1 M HCl, 5 mL of 3 M HCl, and 5 mL of 1 M HCl. The resin was then conditioned with 20 mL of 3 M HNO 3 . The digested sample in 3 M HNO 3 medium (1 mL) or the procedure control solution (1 mL; for definition, see SI Materials and Methods) was then loaded into the column, and matrix elements were eluted with 5 mL of 3 M HNO 3 . Before U elution, the resin was reconditioned with 3.5 mL of 3 M HCl. Finally, U was eluted with 15 mL of 0.5 M HCl and collected into a Savillex vessel. It was verified by quadrupole ICPMS that the major matrix elements of samples (Na, K, P, Mg, Ca, Fe, Zn, Cu, and Mn) were properly separated from U using this protocol. Uranium recoveries during the purification step were of 100 ± 5%. The purified U fraction was dried at 85°C using a heating block. A volume of 0.5 mL of 67 to 70% (wt/vol) HNO 3 was then added to the residues, and the resulting solutions were evaporated to dryness to eliminate chloride rests. Two successive additions of 1 mL 2% (wt/vol) HNO 3 , followed by evaporation, were then performed to minimize the difference in acid matrix composition between samples and mass bias control solutions (for definition, see SI Materials and Methods). Finally, the residue was redissolved in an appropriate volume of 2% (wt/vol) HNO 3 
